# Phase 1 Alzheimer Disease trials recruiting: 46 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 46 trials in phase 1 for Alzheimer Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 Alzheimer Disease trials: 46 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/alzheimer-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 46
- Recruiting or not yet: 46
- Read on: November 19, 2026

## Trials

The 25 newest of 46, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 27, 2026 | NCT07897708 | A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older... | Pfizer | Phase 1 | Not yet recruiting | Alzheimer Disease | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897708) |
| October 22, 2026 | NCT07889349 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy Participants | Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 1 | Not yet recruiting | Alzheimer's Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889349) |
| September 28, 2026 | NCT07843459 | A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD) | Eli Lilly and Company | Phase 1 | Recruiting | Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid, Plasma | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843459) |
| August 31, 2026 | NCT07795307 | Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease | Brigham and Women's Hospital | Phase 1 | Not yet recruiting | Alzheimer's Disease | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795307) |
| August 26, 2026 | NCT07787182 | A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease | Eli Lilly and Company | Phase 1 | Recruiting | Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787182) |
| August 26, 2026 | NCT07787169 | A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease | Eli Lilly and Company | Phase 1 | Recruiting | Alzheimer Disease, Amyloid, Plaque, Amyloid, Healthy Volunteers | 179 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787169) |
| August 21, 2026 | NCT07780383 | A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in... | Bristol-Myers Squibb | Phase 1 | Recruiting | Alzheimer's Disease, Healthy Participants | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780383) |
| August 17, 2026 | NCT07768592 | A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease... | Eisai Inc. | Phase 1 | Not yet recruiting | Alzheimers Disease | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768592) |
| August 11, 2026 | NCT07758595 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's... | Denali Therapeutics Inc. | Phase 1 | Recruiting | Alzheimer's Disease, Healthy Participants | 178 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758595) |
| July 8, 2026 | NCT07690228 | A Study of GSM-779690T in Healthy Adult Participants | Acta Pharmaceuticals | Phase 1 | Recruiting | Healthy Adult Participants, Alzheimer Disease | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07690228) |
| May 20, 2026 | NCT07598370 | A Study of LY3439539 in Participants With Alzheimer's Disease | Eli Lilly and Company | Phase 1 | Recruiting | Alzheimer Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07598370) |
| May 12, 2026 | NCT07580703 | A Phase I Study of \[18F\]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and... | Eli Radiopharma | Phase 1 | Recruiting | AD - Alzheimer's Disease, MCI | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07580703) |
| May 5, 2026 | NCT07568041 | Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients | Cenna Biosciences Inc. | Phase 1 | Not yet recruiting | Alzheimer's Disease (AD) | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07568041) |
| April 28, 2026 | NCT07554872 | Study of Neural Stem Cell-Derived Exosomes in Moderate-to-Severe Early-Onset Alzheimer's Disease | Shanghai Mental Health Center | Phase 1 | Not yet recruiting | Alzheimer Disease (AD) | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554872) |
| April 15, 2026 | NCT07531940 | Escalating Doses of Memantine in Down Syndrome (MEDS-123) | University Hospitals Cleveland Medical Center | Phase 1 | Not yet recruiting | Down Syndrome, Intellectual Disability, Alzheimer Dementia (AD) | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07531940) |
| March 24, 2026 | NCT07489599 | A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's... | Qilu Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI) | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07489599) |
| March 9, 2026 | NCT07458620 | Prospective Single-Arm Safety Study of Cervical LVA in AD Patients | Chang Gung Memorial Hospital | Phase 1 | Not yet recruiting | Alzheimer's Disease (AD) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07458620) |
| February 17, 2026 | NCT07413744 | The Gut - PRO Study | University of Wisconsin, Madison | Phase 1 | Recruiting | Alzheimer Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07413744) |
| January 28, 2026 | NCT07373067 | Repeat Intracerebroventricular Injections of RB-ADSC in Subjects Previously Treated in RBI Protocol RB-ADSC-02 | Regeneration Biomedical, Inc. | Phase 1 | Not yet recruiting | Alzheimer Disease | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07373067) |
| January 12, 2026 | NCT07332260 | Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study | University Hospital of North Norway | Phase 1 | Recruiting | Alzheimer s Disease, Faecal Microbiota Transplantation (FMT) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07332260) |
| January 9, 2026 | NCT07328451 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's... | Denali Therapeutics Inc. | Phase 1 | Recruiting | Alzheimer Disease, Early Onset | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07328451) |
| October 20, 2025 | NCT07218081 | A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers. | Augusta University | Phase 1 | Recruiting | Alzheimer Dementia (AD) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07218081) |
| October 9, 2025 | NCT07214727 | A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease | Alnylam Pharmaceuticals | Phase 1 | Recruiting | Alzheimer's Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07214727) |
| September 8, 2025 | NCT07158905 | AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980) | Institute for Molecular Medicine | Phase 1 | Recruiting | Alzheimer Disease, Preclinical Alzheimer's Disease | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07158905) |
| August 27, 2025 | NCT07143331 | A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers | Klotho Sciences Australia Pty Ltd. | Phase 1 | Not yet recruiting | Healthy Participants, Alzheimer Disease, Chronic Kidney Disease | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07143331) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 6 |
| Denali Therapeutics Inc. | 2 |
| [Alnylam Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/alnylam-pharmaceuticals) | 2 |
| National Institute of Mental Health (NIMH) | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| Amyloid Solution Inc | 1 |
| Brigham and Women's Hospital | 1 |
| [Keymed Biosciences Co.Ltd](https://specstream.ai/data/clinical-trials/company/keymed-biosciences-co-ltd) | 1 |
| Acta Pharmaceuticals | 1 |
| Cenna Biosciences Inc. | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| University of Alabama at Birmingham | 1 |
| Oregon Health and Science University | 1 |
| NYU Langone Health | 1 |
| University of California, San Diego | 1 |
| University College, London | 1 |
| Yale University | 1 |
| Xuanwu Hospital, Beijing | 1 |
| Nuravax, Inc. | 1 |
| University Hospitals Cleveland Medical Center | 1 |
| University Hospital of North Norway | 1 |
| Columbia University | 1 |
| Klotho Sciences Australia Pty Ltd. | 1 |
| R3 Stem Cell | 1 |
| Institute for Molecular Medicine | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 23 |
| China | 9 |
| United Kingdom | 6 |
| Japan | 5 |
| Australia | 3 |
| Netherlands | 3 |
| South Korea | 2 |
| Canada | 2 |
| Taiwan | 2 |
| Spain | 1 |
| Norway | 1 |
| France | 1 |
| New Zealand | 1 |
| Singapore | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Food and beverage exporters in the United States](https://specstream.ai/data/businesses/food-and-beverage-exporters/united-states)
- [Inspection companies in the United States](https://specstream.ai/data/businesses/inspection-companies/united-states)
- [Metal plating companies in the United States](https://specstream.ai/data/businesses/metal-plating-companies/united-states)
- [Plastics companies in the United States](https://specstream.ai/data/businesses/plastics-companies/united-states)
- [Shipping collection companies in the United States](https://specstream.ai/data/businesses/shipping-collection-companies/united-states)
- [Ukrainian restaurants in the United States](https://specstream.ai/data/businesses/ukrainian-restaurants/united-states)
